Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology.

Nat Metab · 2024 · PMC10822775 · PMID 38177805

Europe PMC DOI

hedged sentence

0.4000

closest p · 8.0× alpha

0.4000

boldest claim

The sentences

did not reach statistical significanceP = 0.4not close (p > 0.1)

In contrast, the treatment-by-subgroup interaction for tertiles of HOMA2-B did not reach statistical significance ( P = 0.4, R 2 = 0.46).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.